NCT03989440View on ClinicalTrials.gov

AXER-204 in Participants With Chronic Spinal Cord Injury

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 16, 2019

Primary Completion Date

June 21, 2022

Study Completion Date

June 21, 2022

Conditions
Chronic Spinal Cord Injury
Interventions
DRUG

AXER-204

human NoGo Trap fusion protein

DRUG

Placebo

Phosphate buffered saline formulation

Trial Locations (6)

19107

Thomas Jefferson University, Philadelphia

30309

Shepherd Center, Atlanta

43210

The Ohio State University Wexner Medical Center, Columbus

60611

Shirley Ryan AbilityLab / Northwestern, Chicago

90033

Keck Medicine of USC, Los Angeles

02129

Spaulding Rehabilitation, Boston

All Listed Sponsors
lead

ReNetX Bio, Inc.

INDUSTRY

NCT03989440 - AXER-204 in Participants With Chronic Spinal Cord Injury | Biotech Hunter | Biotech Hunter